According to its SEC filing, YZi Labs seeks to expand BNC’s board and replace directors, opposing governance measures it says limit shareholder consent rights.
YZi Labs released an official statement criticizing CEA Industries’ (BNC) adoption of a poison pill strategy and charter changes, alleging these actions impede shareholder consent rights. In a preliminary consent statement to the U.S. Securities and Exchange Commission, YZi Labs proposed expanding the board and electing its own nominees. The firm disclosed direct ownership of 2,150,481 BNC shares, underscoring its position as a significant shareholder in the governance dispute.